The working capital efficiency at Coda Octopus CODA Q1 2026 Better Than Expected Nu Skin NUS Stock Market Pressure Analysis Nu Skin posts 43 EPS miss revenue not disclosed AQNB Alg P and U 2079 reports Q4 2025 earnings per share 34 percent above consensus estimates shares remain unchanged SILO Silo Pharma rises 557 percent despite reporting a wider than expected Q4 2023 per share loss